| Bioactivity | Coblopasvir (KW-136) is a pangenotypic non-structural protein 5A (NS5A) inhibitor. Coblopasvir can be used for research of chronic hepatitis C virus infection[1]. |
| Name | Coblopasvir |
| CAS | 1312608-46-0 |
| Formula | C41H50N8O8 |
| Molar Mass | 782.88 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Gao Y, et al. Coblopasvir and sofosbuvir for treatment of chronic hepatitis C virus infection in China: A single-arm, open-label, phase 3 trial. Liver Int. 2020;40(11):2685-2693. |
Coblopasvir
CAS: 1312608-46-0 F: C41H50N8O8 W: 782.88
Coblopasvir (KW-136) is a pangenotypic non-structural protein 5A (NS5A) inhibitor. Coblopasvir can be used for research
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.